
New research raises concerns about the commonly prescribed medications used to treat heart failure and high blood pressure, though investigators say patients should continue to take them.


New research raises concerns about the commonly prescribed medications used to treat heart failure and high blood pressure, though investigators say patients should continue to take them.

Inclisiran treats adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease who require additional lowering of low-density lipoprotein cholesterol.

These mothers are approximately 17% less likely to die from cardiovascular disease, 14% less likely to develop coronary heart disease, and 12% less likely to suffer a stroke, the data show.

Ten quiz questions to assess your knowledge on common symptoms and treatments for atrial fibrillation.

Although fewer than 1 in 5 adults with type 2 diabetes are meeting targets to reduce heart disease risk, available therapies can help when combined with new approaches that barriers to care.

Additionally, the study showed a 15-fold increase in maternal mortality rates associated with chronic hypertension over the 40-year study period.

New study results show that though men are more likely to have heart conditions, the impact on their memory and thinking skills is lower.

Results of an analysis from the University of Eastern Finland show that supplementation for 5 years had no effect on total mortality or the incidence of these diseases in older individuals.

These lumps can relate to the overproduction of hormones, including the stress steroid hormone cortisol, which can lead to T2D and high blood pressure.

The approval marks the first small interfering RNA therapy for low-density lipoprotein cholesterol reduction.

Rivaroxaban is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, for the treatment of deep vein thrombosis, and pulmonary embolism.

The research team compared the monthly average blood pressures between 2018 and 2019 with blood pressure measures from January through March 2019 to January through March 2020.

Avapro (Irbesartan) is indicated for the treatment of hypertension and used to lower blood pressure.

Benicar (Olmesartan Medoxomil) is indicated for the treatment of hypertension.

Common triggers for atrial fibrillation include alcohol, caffeine, and less sleep.

Dabigatran and its acyl glucuronides are competitive, direct thrombin inhibitors.

Pharmacists can help to reduce the prevalence of food insecurity and its negative health care outcomes by tailoring clinical care to each individual patient’s needs.

Pharmacists can help patients manage their medications and any adverse effects, and can also educate patients about their condition and treatments.

Pharmacists can play an important role in avoiding common medication errors for patients receiving direct oral anticoagulants.

Rivaroxaban and apixaban are the most commonly prescribed direct oral anticoagulants, although they may be most effective in different populations.

Fibromuscular dysplasia typically appears in the arteries leading to the kidneys and brain.

Assessing stroke benefit and net clinical benefit of anticoagulation is essential in patients with end-stage renal disease and atrial fibrillation.

Patients ages 80 and older have unique considerations when deciding whether to initiate anticoagulation therapy.

Study results also show that the probability of dying from any cause is also 40% higher for individuals who have cardiovascular disease.

The long-term implications of post-COVID-19 myocardial injury detected by cardiac MRI are still unknown.